Anna Koromyslova

Title: Anna Koromyslova: Innovator in Norovirus Research

Introduction

Anna Koromyslova is a prominent inventor based in Dossenheim, Germany. She has made significant contributions to the field of virology, particularly in the development of innovative solutions for detecting and treating norovirus infections. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics and therapeutics.

Latest Patents

Anna's latest patents focus on the development of binding polypeptides that specifically target norovirus capsid proteins. The first patent describes a binding polypeptide that interacts with an epitope within the amino acid sequence of the norovirus genotype II.10 capsid polypeptide. This invention also includes a composition that combines the binding polypeptide with a carrier, which can be utilized in diagnostic applications and medical treatments. The second patent outlines a binding polypeptide that recognizes a specific amino acid sequence in norovirus polypeptides, along with methods for detecting norovirus capsid proteins in samples. These innovations have the potential to enhance diagnostic accuracy and therapeutic options for norovirus infections.

Career Highlights

Throughout her career, Anna has worked with esteemed institutions such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Ruprecht-Karls-University Heidelberg. Her experience in these research environments has contributed to her expertise in virology and molecular biology.

Collaborations

Anna has collaborated with notable professionals in her field, including Grant Hansman, further enriching her research endeavors and expanding the impact of her work.

Conclusion

Anna Koromyslova's innovative contributions to norovirus research exemplify her dedication to advancing medical science. Her patents and collaborations highlight her role as a key figure in the fight against viral infections.